Neubase Therapeutics, Inc.
NBSE
Revenue
0.00
0.000.00%
-Assets
18.62M
▼-3.71M▼-16.62%
3 Months ChangeLiabilities
9.48M
▼-1.60M▼-14.46%
3 Months ChangeFree Cash Flow
-3.46M
▲2.28M▲39.67%
3 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-06-27
Form 8-K
ID: 0001104659-24-075711
2024-05-31
Form 8-K
ID: 0001104659-24-067212
2024-05-22
Form 8-K
ID: 0001104659-24-064320
2024-05-13
Form 8-K
ID: 0001104659-24-060568
2024-05-03
Form 8-K
ID: 0001104659-24-056957
2024-04-05
Form 8-K
ID: 0001104659-24-044287
2024-03-07
Form 8-K
ID: 0001104659-24-031876
2024-02-23
Form 8-K
ID: 0001104659-24-027005
2024-01-26
Form 8-K
ID: 0001104659-24-007014
2024-01-17
Form 8-K
ID: 0001104659-24-004247